AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 124 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,608,000 | +110.9% | 238,464 | +4.6% | 0.00% | – |
| Q2 2022 | $1,711,000 | -15.1% | 228,059 | +3.0% | 0.00% | – |
| Q1 2022 | $2,015,000 | +43.6% | 221,411 | +10.9% | 0.00% | – |
| Q4 2021 | $1,403,000 | -38.4% | 199,654 | -0.2% | 0.00% | – |
| Q3 2021 | $2,279,000 | -24.8% | 199,991 | +5.7% | 0.00% | -100.0% |
| Q2 2021 | $3,029,000 | -20.7% | 189,198 | -11.5% | 0.00% | 0.0% |
| Q1 2021 | $3,822,000 | +30.3% | 213,846 | -1.5% | 0.00% | 0.0% |
| Q4 2020 | $2,934,000 | -80.5% | 217,160 | -83.0% | 0.00% | -75.0% |
| Q3 2020 | $15,010,000 | -20.9% | 1,275,272 | -0.7% | 0.00% | -20.0% |
| Q2 2020 | $18,965,000 | +4.0% | 1,284,820 | -4.9% | 0.01% | -16.7% |
| Q1 2020 | $18,237,000 | -45.6% | 1,350,758 | -2.7% | 0.01% | -33.3% |
| Q4 2019 | $33,541,000 | +29.8% | 1,387,682 | +3.2% | 0.01% | +28.6% |
| Q3 2019 | $25,833,000 | -44.1% | 1,344,049 | -14.0% | 0.01% | -46.2% |
| Q2 2019 | $46,208,000 | -43.9% | 1,563,721 | -9.8% | 0.01% | -43.5% |
| Q1 2019 | $82,322,000 | +55.5% | 1,733,080 | +18.2% | 0.02% | +35.3% |
| Q4 2018 | $52,928,000 | +36.3% | 1,466,119 | +132.4% | 0.02% | +70.0% |
| Q3 2018 | $38,826,000 | -8.9% | 630,815 | +0.0% | 0.01% | -16.7% |
| Q2 2018 | $42,597,000 | +31.3% | 630,612 | +5.5% | 0.01% | +33.3% |
| Q1 2018 | $32,431,000 | -11.5% | 597,792 | -2.5% | 0.01% | -10.0% |
| Q4 2017 | $36,645,000 | +37.0% | 613,305 | +11.5% | 0.01% | +42.9% |
| Q3 2017 | $26,743,000 | +16.5% | 550,275 | +25.9% | 0.01% | +16.7% |
| Q2 2017 | $22,962,000 | +91.0% | 436,955 | +64.8% | 0.01% | +100.0% |
| Q1 2017 | $12,021,000 | +61.4% | 265,076 | +34.8% | 0.00% | +50.0% |
| Q4 2016 | $7,446,000 | +23.7% | 196,716 | +23.3% | 0.00% | 0.0% |
| Q3 2016 | $6,019,000 | +158.9% | 159,497 | +20.7% | 0.00% | +100.0% |
| Q2 2016 | $2,325,000 | +46.1% | 132,146 | +1.0% | 0.00% | – |
| Q1 2016 | $1,591,000 | -48.6% | 130,834 | +2.9% | 0.00% | -100.0% |
| Q4 2015 | $3,096,000 | +35.4% | 127,155 | -1.3% | 0.00% | 0.0% |
| Q3 2015 | $2,286,000 | +29.8% | 128,834 | +29.1% | 0.00% | – |
| Q2 2015 | $1,761,000 | -37.4% | 99,767 | +11.2% | 0.00% | -100.0% |
| Q1 2015 | $2,813,000 | +5.5% | 89,740 | -1.7% | 0.00% | 0.0% |
| Q4 2014 | $2,666,000 | +62.0% | 91,331 | +14.8% | 0.00% | – |
| Q3 2014 | $1,646,000 | -13.9% | 79,523 | +3.0% | 0.00% | – |
| Q2 2014 | $1,912,000 | +174.3% | 77,184 | +134.5% | 0.00% | – |
| Q1 2014 | $697,000 | +64.0% | 32,911 | +39.2% | 0.00% | – |
| Q4 2013 | $425,000 | – | 23,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|